KEY POINTS

  • A U.K. woman suffered disfigurement after receiving a shot of the AstraZeneca vaccine
  • The 49-year-old Staffordshire resident said her skin bubbled hours after the shot
  • She had been on liquid morphine and codeine at the time of vaccination

A U.K. woman suffered from an extreme allergic reaction, including disfigurement, after she received a shot of the AstraZeneca COVID-19 vaccine on March 18, according to a recent report.

Susie Forbes, 49, of Lichfield, Staffordshire, said she suffered disfigurement that made her feel like a creature in the sci-fi movie “Alien” after a rash broke out and her skin bubbled hours after getting a dose of the Oxford-AstraZeneca vaccine, she told Triangle News.

“It felt like I was in ‘Alien’ because there were bubbles coming out of my arm. It was horrific. My face was huge. I was a monster,” Forbes told the U.K. publication, according to the New York Post.

“My daughter was texting me begging me to go to hospital. It’s destroyed me and destroyed my daughter. I’m going to have to live with this as I have scars on my body,” she added.

Forbes was taking liquid morphine and codeine for a fractured wrist at the time of her vaccination. She was also on several other medications, including Gabapentin and Tramadol. The 49-year-old believes doctors should have taken her medical history in consideration before administering the dose.

“I personally think they haven’t looked at exactly what I’ve got. I think they shouldn’t have given it to me until they investigate what you have. They didn’t even ask me,” she continued.

On April 6, Marco Cavaleri, chair of the European Medicines Agency's vaccine evaluation team, announced that the EMA found a direct link between AstraZeneca’s COVID-19 vaccine to a rare blood-clotting disorder seen in numerous patients.

The announcement prompted Denmark to announce Tuesday that it would stop administering the AstraZeneca vaccine to its residents, becoming the first European country to do so following news of the blood-clotting disorder.

“Based on the scientific findings, our overall assessment is there is a real risk of severe side effects associated with using the Covid-19 vaccine from AstraZeneca,” Soren Brostrom, director general of the Danish Health Authority, said in a statement. “We have, therefore, decided to remove the vaccine from our vaccination program.”

The European Commission on Wednesday revealed that it does not plan to renew its COVID-19 vaccine contract with AstraZeneca at its expiry. It added that it would focus on the use of Pfizer’s and Moderna’s vaccines, which utilize mRNA technology.

“The European Commission, in agreement with the leaders of many (EU) countries, has decided that the contracts with the companies that produce (viral vector) vaccines that are valid for the current year will not be renewed at their expiry,” an official at the Italian health ministry told Italian paper La Stampa, according to Reuters.

Germany announced on March 30 that it would no longer offer the two-dose AstraZeneca vaccine to people aged under 60 due to concerns over a possible link to rare cases of blood clots
Germany announced on March 30 that it would no longer offer the two-dose AstraZeneca vaccine to people aged under 60 due to concerns over a possible link to rare cases of blood clots AFP / JUSTIN TALLIS